Nebulised therapies for use at home

Clinical Indication

Asthma and COPD

Comments

Exception palliative care

Please see nebuliser guidance and MHRA alert

Date of classification

November 2022

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .